US Patent 11351246 Recombinant measles vaccine expressing hTERT
Is a
Date Filed
May 7, 2018
Date of Patent
June 7, 2022
Patent Application Number
16611786
Patent Inventor Names
Pierre Langlade Demoyen
0
Elodie Pliquet
0
Frédéric Tangy
0
Patent Jurisdiction
Patent Number
Patent Primary Examiner
Find more entities like US Patent 11351246 Recombinant measles vaccine expressing hTERT
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
